Podocytes and the struggle against glucose toxicity: new targets for treatment?

PubWeight™: 0.75‹?›

🔗 View Article (PMID 22386941)

Published in Metabolism on March 03, 2012

Authors

Luigi Gnudi

Articles by these authors

Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial. Lancet (2010) 2.55

Podocyte-specific expression of angiopoietin-2 causes proteinuria and apoptosis of glomerular endothelia. J Am Soc Nephrol (2007) 2.06

Angiopoietin-1 therapy enhances fibrosis and inflammation following folic acid-induced acute renal injury. Kidney Int (2008) 1.70

IGF-I induces vascular endothelial growth factor in human mesangial cells via a Src-dependent mechanism. Kidney Int (2003) 1.43

Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice. Diabetes (2008) 1.21

Roles of angiopoietins in kidney development and disease. J Am Soc Nephrol (2008) 1.07

Mechanical stretch induces monocyte chemoattractant activity via an NF-kappaB-dependent monocyte chemoattractant protein-1-mediated pathway in human mesangial cells: inhibition by rosiglitazone. J Am Soc Nephrol (2005) 1.04

Mechanical forces and TGFbeta1 reduce podocyte adhesion through alpha3beta1 integrin downregulation. Nephrol Dial Transplant (2009) 0.98

A role for TRPV1 in influencing the onset of cardiovascular disease in obesity. Hypertension (2012) 0.98

Targeted glomerular angiopoietin-1 therapy for early diabetic kidney disease. J Am Soc Nephrol (2013) 0.98

Albuminuria is associated with too few glomeruli and too much testosterone. Kidney Int (2013) 0.93

Endothelial factors and diabetic nephropathy. Diabetes Care (2011) 0.91

Pioglitazone improves in vitro viability and function of endothelial progenitor cells from individuals with impaired glucose tolerance. PLoS One (2012) 0.90

Effect of renin-angiotensin system blockade on soluble Klotho in patients with type 2 diabetes, systolic hypertension, and albuminuria. Clin J Am Soc Nephrol (2013) 0.89

Fluorescence-based sensing of glucose using engineered glucose/galactose-binding protein: a comparison of fluorescence resonance energy transfer and environmentally sensitive dye labelling strategies. Biochem Biophys Res Commun (2007) 0.89

An ongoing role of α-calcitonin gene-related peptide as part of a protective network against hypertension, vascular hypertrophy, and oxidative stress. Hypertension (2014) 0.89

Circulating vascular progenitor cells in patients with type 1 diabetes and microalbuminuria. Diabetes Care (2010) 0.88

Glucose induces increases in levels of the transcriptional repressor Id2 via the hexosamine pathway. Am J Physiol Endocrinol Metab (2005) 0.86

VEGF and angiopoietins in diabetic glomerulopathy: how far for a new treatment? Metabolism (2012) 0.85

N-3 PUFA increase bioavailability and function of endothelial progenitor cells. Food Funct (2014) 0.83

Effect of spironolactone and amiloride on thiazolidinedione-induced fluid retention in South Indian patients with type 2 diabetes. Clin J Am Soc Nephrol (2012) 0.81

Peroxisome proliferator-activated receptor-γ agonist rosiglitazone prevents albuminuria but not glomerulosclerosis in experimental diabetes. Am J Nephrol (2010) 0.81

Non-invasive glucose monitoring by NAD(P)H autofluorescence spectroscopy in fibroblasts and adipocytes: a model for skin glucose sensing. Diabetes Technol Ther (2003) 0.80

ACCORD and ADVANCE: a tale of two studies on the merits of glycaemic control in type 2 diabetic patients. Nephrol Dial Transplant (2008) 0.80

Circulating vascular progenitor cells and central arterial stiffness in polycystic ovary syndrome. PLoS One (2011) 0.79

High prevalence of cardio-metabolic risk factors in a young urban Sri-Lankan population. PLoS One (2012) 0.78

Renin angiotensin aldosterone system (RAAS) inhibitors in the prevention of early renal disease in diabetes. F1000 Med Rep (2010) 0.78

Influence of depression and anxiety on circulating endothelial progenitor cells in patients with acute coronary syndromes. Hum Psychopharmacol (2015) 0.77

Future strategies to prevent renal microvascular disease complications in diabetes. Future Cardiol (2008) 0.77

DIABRISK-SL prevention of cardio-metabolic disease with life style modification in young urban Sri Lankan's--study protocol for a randomized controlled trial. Trials (2011) 0.75

Serum intact parathyroid hormone in diabetic patients on haemodialysis: what is the treatment goal? Nephrol Dial Transplant (2007) 0.75

The link between mechanical stretch and glucose metabolism--a conceptual advance in understanding diabetic (and non diabetic?) renal disease. Nephrol Dial Transplant (2006) 0.75